Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Colitis, Ulcerative Clinical Trials

9 recruiting trials for Colitis, Ulcerative. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
9
Total Trials
9
Recruiting Now
0
Phase 3 Trials
9
Sponsors

Recruiting Trials

RECRUITINGNCT06246123

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

The purpose of this study is to collect and evaluate the following information in relation to the safety and the efficacy of Jyseleca tablet (Filgotinib Maleate) 100 milligram...

Sponsor: Eisai Korea Inc.Enrolling: 204020 locations
RECRUITINGNCT06065228

Therapeutic Endpoint in Pediatric IBD Conditions

The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically...

Sponsor: Children's National Research InstituteEnrolling: 601 location
RECRUITINGNCT07242248

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's...

The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the...

Sponsor: Janssen-Cilag Ltd.Enrolling: 2201 location
RECRUITINGNCT07102368

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated with Guselkumab in a real-world setting, and to assess the...

Sponsor: Janssen-Cilag G.m.b.HEnrolling: 4001 location
RECRUITINGPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative...

The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally...

Sponsor: Bristol-Myers SquibbEnrolling: 12020 locations
RECRUITINGNCT05456412

JAK Inhibition in Ulcerative Colitis

The treatment for Ulcerative Colitis (UC) aims to achieve and maintain remission and is usually lifelong and expensive. Current available medications are unable to break the cycle...

Sponsor: Leiden University Medical CenterEnrolling: 601 location
RECRUITINGNCT04121806

Diet Intervention Treatment for Active Ulcerative Colitis

The purpose of this study is to determine if a sustainable non-elemental diet can be used as a probiotic tool to alter the dysbiotic microbiome found in individuals with...

Sponsor: Mount Sinai Hospital, CanadaEnrolling: 201 location
RECRUITINGNCT06294925

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

The purpose of this real world non-interventional study is to learn about the effects of etrasimod as treatment for patients with moderate to severe ulcerative colitis. Patients...

Sponsor: PfizerEnrolling: 36020 locations
RECRUITINGPhase 2NCT06867094

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

This is a Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with...

Sponsor: SanofiEnrolling: 20420 locations